Skip to main content
SpringerLink
Log in

Endometrial hyperplasia: recent updates and clinicopathological correlation

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Endometrial carcinoma is one of the most common carcinomas affecting women worldwide, and detecting them at the level of precursor lesions can reduce the morbidity and mortality. The aim of this study is to perform a comparative analysis of the two- and four-tier systems on the basis of clinical features and establishe a clinico-pathological correlation. A 5-year study was conducted on histopathologically diagnosed cases of endometrial hyperplasia from the gynecological specimens received in the department of Pathology. The study included 34 cases of endometrial hyperplasia. Hyperplasia without atypia (91.2%) and simple hyperplasia without atypia (82.35%) was the most common type as per the two- and four-tier system, respectively. Hyperplasia without atypia was most common in the fourth to fifth decade of life (54.84%), atypical hyperplasia in the third to fifth decade of life (66.66%), and EIN presented after the sixth decade of life. Hyperplasia without atypia presented most commonly with menorrhagia (64.52%) and atypical hyperplasia/EIN with post-menopausal bleeding (66.66%). Both were more common in multiparous women (87.10 and 66.66%, respectively). Morphologically, variable-sized glands with cystic dilatation (70.6%) and the absence of atypia (91%) was most common. The case of EIN was associated with endometrioid adenocarcinoma. Leiomyoma (3 cases), adenomyosis (2 cases), and endometritis (1 case) were the associated lesions. Abnormal uterine bleeding should raise a suspicion of endometrial hyperplasia, and every specimen received should be examined thoroughly, because histopathological examination is essential to give the diagnosis. Endometrial hyperplasia without atypia was the commonest type diagnosed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • American College of Obstetricians and Gynecologists (2005) ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106:413–425

    Article  Google Scholar 

  • Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R (2016) Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol 27(1):e8

    Article  PubMed  Google Scholar 

  • Ellenson LH, Ronnett BM, Kurman RJ (2011) Precursor lesions of endometrial carcinoma. In: Blaustein’s pathology of the female genital tract, 6th edn. Springer, New York, pp 359–391

  • Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183–198

    Article  CAS  PubMed  Google Scholar 

  • Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS (2008) Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol 168(6):563–570

    Article  PubMed  PubMed Central  Google Scholar 

  • Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ (1998) Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22:1012–1019

    Article  CAS  PubMed  Google Scholar 

  • Kurman RJ, Norris HJ (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49:2547–2559

    Article  CAS  PubMed  Google Scholar 

  • Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. a long-term study of “untreated” hyperplasia in 170 patients. Cancer 56:403–412

    Article  CAS  PubMed  Google Scholar 

  • Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014a) WHO classification of Tumors of Female Reproductive Organs. In: Preface. IARC, Lyon, pp 9

  • Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014b) WHO classification of tumors of female reproductive organs. In: Chapter 5 – tumors of the uterine corpus. IARC, Lyon, pp 121–154

  • Lacey JV Jr, Mutter GL, Nucci MR, Ronnett BM, Ioffe OB, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME (2008) Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 113(8):2073–2081

    Article  PubMed  PubMed Central  Google Scholar 

  • Lacey JV Jr, Chia VM, Rush BB, Carreon DJ, Richesson DA, Loffe OB, Ronnett BM, Chatterjee N, Langholz B, Sherman ME, Glass AG (2012) Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. Int J Cancer 131(8):1921–1929

    Article  CAS  PubMed  Google Scholar 

  • Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Muñoz J, Argüelles R, Machin P, Prat J (2001) Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32(6):569–577

    Article  CAS  PubMed  Google Scholar 

  • Mazur MT (1981) Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 5:473–482

    Article  CAS  PubMed  Google Scholar 

  • Mutter GL, Baak JP, Crum CP, Richart RM, Ferenczy A, Faquin WC (2000) Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 190(4):462–469

    Article  CAS  PubMed  Google Scholar 

  • Muzaffar M, Akhtar KA, Yasmin S, Mahmood-Ur-Rehman IW, Khan MA (2005) Menstrual irregularities with excessive blood loss: a clinico-pathological correlation. J Pak Med Assoc 55:486–489

    PubMed  Google Scholar 

  • O’Dowd MJ, Philipp EE (1994) Cancer of the uterus. The history of obstetrics and gynaecology, 1st edn. Parthenon Publishing Group, New York, pp 571–580

    Google Scholar 

  • Rahimi S, Marani C, Renzi C, Natale ME, Giovannini P, Zeloni R (2009) Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol 28(6):522–528

    Article  PubMed  Google Scholar 

  • Rao S, Sundaram S, Narasimhan R (2009) Biological behavior of preneoplastic conditions of the endometrium: a retrospective 16 year study in south India. Indian J Med Paediatr Oncol 30:131–135

    Article  PubMed  PubMed Central  Google Scholar 

  • Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, Voigt LF, Weiss NS (2009) Incidence of endometrial hyperplasia. Am J Obstet Gynecol 200:678.e1–678.e6

    Article  Google Scholar 

  • Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, Salerio B, Polverino G, La Vecchia C (2002) Risk factors for endometrial hyperplasia: results from a case-control study. Int J Gynecol Cancer 12:257–260

    Article  CAS  PubMed  Google Scholar 

  • Sanderson PA, Critchley HD, Williams AW, Arends MJ, Saunders PK (2017) New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update 23(2):232–254

    PubMed  Google Scholar 

  • Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ (eds) (1994) Histological typing of female genital tract tumors. International histological classification of tumors, 2nd edn. Springer, Berlin

    Google Scholar 

  • Silverberg SG (2000) Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13(3):309–327

    Article  CAS  PubMed  Google Scholar 

  • Takreem A, Danish N, Razaq S (2009) Incidence of endometrial hyperplasia in 100 cases presenting with polymenorrhagia/menorrhagia in perimenopausal women. J Ayub Med Coll Abbottabad 21:60–63

    PubMed  Google Scholar 

  • The Writing Group for the PEPI Trial (1996) Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmeonpausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 275(5):370–375

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Government Medical College, Miraj, Sangli, Maharashtra, 416410, India

    Divya Shekhar Shetty, Alka Vikas Gosavi, Prashant Shankarrao Murarkar & Kalpana Ranjitsingh Sulhyan

Authors
  1. Divya Shekhar Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alka Vikas Gosavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prashant Shankarrao Murarkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kalpana Ranjitsingh Sulhyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Divya Shekhar Shetty.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shetty, D.S., Gosavi, A.V., Murarkar, P.S. et al. Endometrial hyperplasia: recent updates and clinicopathological correlation. Comp Clin Pathol 27, 199–204 (2018). https://doi.org/10.1007/s00580-017-2578-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-017-2578-0

Keywords

Search

Navigation